ADIPOR1 and colorectal carcinoma: As inconsistent results were found for studies evaluated the associations between variants on ADIPOQ or ADIPOR1 and CRC risk, we also performed the meta-analysis studies of the published epidemiological studies to systematically evaluate the associations between variants of ADIPOQ and ADIPOR1 and the CRC risk.